Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof

Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof

US Patent 10954301 · Granted Mar 23, 2021

Estimated economic value: $115,266,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-PD-1 antibodies and uses thereof2025
CD137 binding molecules and uses thereof2025
CD137 binding molecules and uses thereof2025
CD137 binding molecules and uses thereof2025
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
CD3-binding molecules capable of binding to human and non-human CD32024
HER2/neu-specific antibodies and methods of using same2024
HER2/neu-specific antibodies and methods of using same2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024